SENSEX 80,248.08

+ 445.29

NIFTY 24,276.05

+ 144.95

CRUDEOIL 5,780.00

-34.00

GOLD 76,062.00

-312.00

SILVER 88,774.00

-107.00

SENSEX 80,248.08

+ 445.29

NIFTY 24,276.05

+ 144.95

NIFTY 24,276.05

+ 144.95

CRUDEOIL 5,780.00

-34.00

CRUDEOIL 5,780.00

-34.00

GOLD 76,062.00

-312.00

Cipla Ltd News Today

BSE - 500087
NSE - CIPLA
ISIN - INE059A01026

Markets
Stocks that will see action on July 15, 2022
Markets
Stocks that will see action today (June 28)
Companies
Geopolitical challenges across the world cast a shadow of uncertainty: Cipla CEO
Companies
Cipla clarifies on promoter stake sale; for personal and philanthropic purposes
Companies
Torrent, Cipla, Sun announce branded versions of molnupiravir in India
Torrent to sell the anti-viral drug under brand name Molnutor, Cipla under brand Cipmolnu and Sun Pharmaceuticals under brand Molxvir
Companies
Cipla introduces portable wireless spirometer for diagnosis of COPD, asthma
With the introduction of Spirofy, the company aims to help doctors to improve the lives of patients.
Companies
Cipla to sell Lilly’s Trulicity, Humalog diabetes treatments in India
The deal will allow Cipla to expand access to the drugs in the country with the second-highest number of diabetic people in the world
Stocks
Cipla records fresh highs on nod for Moderna’s Covid-19 vaccine
Cipla was trading at ₹975.25 on the BSE, down ₹3.80 or 0.39 per cent
News
Moderna’s Covid vaccine gets nod for restricted use
Cipla says it is part of US donation, only helping with regulatory norms
News
Close to commit over $1-b to Moderna for booster vaccine: Cipla to Govt
Need support of the government to make the program successful, said Cipla
Companies
Roche’s antibody cocktail launched in India at ₹59,750/dose
Cipla to market drug in country
National
Karnataka threatens action against Cipla and Jubilant
Issues notice to the companies for failure to supply requisite quantity of Remdesivir to the State as directed by the Centre

Sign into Unlock benefits!

Access 10 free stories per month
Access to comment on every story
Sign up/Manage to our newsletters
Get notified by email for early preview to new features, discounts & offers